Terms: = Colorectal cancer AND GATA2, NFE1B, 2624, ENSG00000179348, MGC2306, P23769 AND Prognosis
5 results:
1. The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta-analysis and systematic review.
Lu B; Qian JM; Li JN
J Gastroenterol Hepatol; 2023 Feb; 38(2):187-196. PubMed ID: 36287138
[TBL] [Abstract] [Full Text] [Related]
2. GATA binding protein 2 overexpression is associated with poor prognosis in KRAS mutant colorectal cancer.
Xu K; Wang J; Gao J; Di J; Jiang B; Chen L; Wang Z; Wang A; Wu F; Wu W; Shen L; Su X
Oncol Rep; 2016 Sep; 36(3):1672-8. PubMed ID: 27460045
[TBL] [Abstract] [Full Text] [Related]
3. [Expression of NF-E1b in colorectal cancer tissues and its clinical significance].
Xu K; Chen L; Di J; Wang Z; Wang A; Wu W; Wu F; Jiang B; Su X
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Jun; 19(6):685-9. PubMed ID: 27353105
[TBL] [Abstract] [Full Text] [Related]
4. gata2 rs2335052 Polymorphism Predicts the Survival of Patients with colorectal cancer.
Liu X; Jiang B; Wang A; Di J; Wang Z; Chen L; Su X
PLoS One; 2015; 10(8):e0136020. PubMed ID: 26287967
[TBL] [Abstract] [Full Text] [Related]
5. Expression and prognostic significance of GATA-binding protein 2 in colorectal cancer.
Chen L; Jiang B; Wang Z; Liu M; Ma Y; Yang H; Xing J; Zhang C; Yao Z; Zhang N; Cui M; Su X
Med Oncol; 2013 Jun; 30(2):498. PubMed ID: 23423786
[TBL] [Abstract] [Full Text] [Related]